It's so nefarious. Right? Recall perhaps the good old days when K was promising and there was Bologna and leukemia chatter, not to mention BI Deaconess and IP trials for Renal CA. And then the B OM interim data, so lovely as predicted by the Sonis model?
Can you follow? Have you paid attention over years?
Then what about the pathetic drivel we were subjected to about P2b? And what about the oh so ugly B OM subset data?
Let us take me, as an early investor , attracted by a new therapeutic class, a lovely synthetic small molecule, that had so much promise as an antibacterial and anti inflammatory agent.
But big pharma would not pick up skin structure B- I thought they would. One day they might. K was paired briefly with Mayo clinic in addition to all the Harvard connections- but then it came to naught.
I would argue that if you- this is a generic you- have not spent years complaining and unhappy then you are not paying attention or you do not care at all, about the fate of IP.
Because the P and B OM debacles were very ugly.
Out of the blue it's B for c- who knows, maybe so. But Leo cannot go to warp! Or is it the RBL? Who knows, does not feel right though.
Behind it all- a faith in a brand new type of therapy with B, a B UP trial that is very compelling even if not blinded, and hope for B UC. That is why people who are sad and demoralized over many many years still care about the company, and still have hopes for better days.
I have just the opposite perspective- why don't more people complain? Why aren't shareholders up in arms over pathetic communication from IP when there is a national emergency? B for c- sure Leo, but what about who is doing what and where and how?
I think we should care and complain more not less
